To Evaluate the Bioavailability of a Tablet of AZD1656

Completed · Phase 1

Conditions studied: Type 1 Diabetes

In brief

To evaluate the bioavailability of a tablet of AZD1656.

Key facts

Study ID

NCT00817505

Run by

AstraZeneca

People needed

11

Starts

2008-12-01

Expected to finish

2009-09-01

Last updated by the study team

2009-11-03

Who can join

Age: 20 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, type I diabetes patients, female with non child-bearing potential.
• Treated with insulin for more than 3 years. Well controlled HbA1c.
• Have a body mass index (BMI) ≥19 and ≤35

You may not qualify if…

• Clinically significant illness except type I diabetes, or clinically relevant trauma, as judged by the investigator, within 2 weeks before the first administration of the investigational product
• Daily use of nicotine containing substances.

Where it is running

• Research site — San Antonio, Texas, United States
• Research site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.